PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant Genetic Test sale cost 4400 AED
REEP2 Gene SPG72 Genetic Test sale cost 4400 AED REEP2 Gene SPG72 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
PLEKHG4 Gene Spinocerebellar Ataxia Type 4 Autosomal Dominant Genetic Test sale cost 4400 AED PLEKHG4 Gene Spinocerebellar Ataxia Type 4 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PRKCG gene, which are known to cause Spinocerebellar Ataxia Type 14 (SCA14). SCA14 is a form of spinocerebellar ataxia, a neurodegenerative disorder characterized by progressive problems with movement, coordination, and balance, due to degeneration of the cerebellum and its connections. It is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.

This test is particularly crucial for individuals with a family history of SCA14, displaying symptoms of the condition, or couples planning to have children and wanting to assess the risk of passing the condition onto their offspring. By analyzing the DNA to detect mutations in the PRKCG gene, this test can confirm a diagnosis of SCA14, assist in the management and treatment of the condition, and provide essential information for genetic counseling.

The test is offered by DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost of the PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant Genetic Test is 4400 AED. Given the complexity of the condition and the implications of the test results, individuals are often advised to undergo genetic counseling before and after the test to fully understand the potential outcomes and their impact.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant Genetic Test

At DNA Labs UAE, we offer the PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant Genetic Test. This test helps diagnose Spinocerebellar Ataxia Type 14 (SCA14), a rare genetic disorder that affects the central nervous system, specifically the cerebellum.

Test Components

The test includes the following components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with SCA14.

Test Details

SCA14 is an autosomal dominant condition caused by mutations in the PRKCG gene located on chromosome 19. These mutations result in the production of a faulty protein called protein kinase C gamma (PKC), which disrupts the normal functioning of the cerebellum.

The NGS (Next-Generation Sequencing) genetic testing technique allows for the simultaneous analysis of multiple genes or the entire genome. In the case of SCA14, the NGS genetic test identifies mutations in the PRKCG gene. A DNA sample is obtained, typically through a blood sample or a cheek swab, and then sequenced using NGS technology to detect variations or mutations in the PRKCG gene.

If a mutation is identified, it confirms the diagnosis of SCA14. Genetic testing for SCA14 can be beneficial for individuals with a family history of the condition or those experiencing symptoms associated with ataxia. It helps confirm the diagnosis, provides information about disease progression and prognosis, and assists in family planning and genetic counseling.

It is important to note that genetic testing for SCA14 should be performed by healthcare professionals or genetic counselors specializing in genetic disorders. They can provide guidance and support throughout the testing process and help interpret the results.

Test Name PRKCG Gene Spinocerebellar ataxia type 14 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PRKCG Gene Spinocerebellar ataxia type 14, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PRKCG Gene Spinocerebellar ataxia type 14, autosomal dominant
Test Details

Spinocerebellar ataxia type 14 (SCA14) is a rare genetic disorder that affects the central nervous system, specifically the cerebellum. It is an autosomal dominant condition, meaning that individuals who carry a single copy of the mutated gene will develop the disease.

The PRKCG gene, located on chromosome 19, is associated with SCA14. Mutations in this gene lead to the production of a faulty protein called protein kinase C gamma (PKC). This abnormal protein disrupts the normal functioning of the cerebellum, leading to the symptoms of SCA14.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of SCA14, an NGS genetic test can be used to identify mutations in the PRKCG gene.

The NGS genetic test for SCA14 involves obtaining a DNA sample, typically through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology, which can detect variations or mutations in the PRKCG gene. If a mutation is identified, it confirms the diagnosis of SCA14.

Genetic testing for SCA14 can be beneficial for individuals who have a family history of the condition or for those who are experiencing symptoms associated with ataxia. It can help confirm the diagnosis, provide information about disease progression and prognosis, and assist in family planning and genetic counseling.

It is important to note that genetic testing for SCA14 is typically performed by healthcare professionals or genetic counselors who specialize in genetic disorders. They can provide guidance and support throughout the testing process and help interpret the results.

SKU: TEST-2058 Category:

Related products